P19-25. A vaccine model to prevent the depletion of uninfected bystander CD4 cells during HIV infection

por Vieillard, V, Fausther-Bovendo, H, Le Grand, R, Debre, P
Publicado 2009

OA031-05. HIV escape from natural killer cytotoxicity: Nef inhibits NKp44L expression on HIV-infected CD4+ T cells

por Fausther-Bovendo, H, Sol-Foulon, N, Schwartz, O, Debre, P, Vieillard, V
Publicado 2009

Hospital compounding to face shortage: A case study of the development of a lopinavir-ritonavir oral suspension during the first wave of SARS-COV-2 in France

por Secretan, P.-H., Thirion, O., Vieillard, V., Saunier, J., Razazi, K., Paul, M., Do, B.
Publicado 2022

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple...

por Bendenoun, M., Samri, A., Avettand-Fènoël, V., Cardinaud, S., Descours, B., Carcelain, G., Mazeron, M.-C., Bergmann, J.-F., Urrutia, A., Moris, A., Rouzioux, C., Simon, F., Andre, P., Pocard, M., Dray, X., Mourez, T., Vieillard, V., Autran, B., Barin, F., Sellier, P.
Publicado 2017